Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - theophylline, quantity: 20.63 mg/ml; ethylenediamine, quantity: 5.477 mg/ml; ethylenediamine - injection, solution - excipient ingredients: water for injections - aminophylline injection bp is indicated for the treatment of reversible bronchospasm associated with chronic bronchitis, emphysema, bronchial asthma and chronic obstructive pulmonary disease. it may also be used for paroxysmal dyspnoea associated with left heart failure.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - labetalol hydrochloride, quantity: 50 mg - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - the emergency treatment of severe hypertension when prompt and urgent reduction of blood pressure is essential

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

bioq pharma pty ltd - ropivacaine hydrochloride monohydrate, quantity: 2.116 mg/ml (equivalent: ropivacaine hydrochloride, qty 2 mg/ml) - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium hydroxide; water for injections - ropivacaine readyfusor (0.2% ropivacaine solution for injection) is indicated for: ? continuous peripheral nerve block infiltration for postoperative pain management in adults ? continuous wound infiltration for postoperative pain management in adults,(data for peripheral nerve block administered as a continuous peripheral infusion and for continuous wound infusion support the use for up to 48 hours only).

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - clonidine hydrochloride, quantity: 150 microgram/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - mz clonidine hcl injection is indicated for acute hypertensive crisis and as an alternative to oral therapy where the oral route of administration is inappropriate.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - clonidine hydrochloride, quantity: 150 microgram/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - clonidine hci injection medsurge is indicated for acute hypertensive crisis and as an alternative to oral therapy where the oral route of administration is inappropriate.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ephedrine sulfate, quantity: 30 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - ephedrine is indicated in the treatment of shock unresponsive to fluid replacement. it is also indicated in the treatment of hypotension secondary to spinal anaesthesia. ephedrine sulfate injection has also been used in the treatment of bronchial asthma and reversible bronchospasm although more selective agents (beta adrenergic agonists) are now available.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - isoprenaline hydrochloride, quantity: 1 mg - injection, solution - excipient ingredients: sodium citrate dihydrate; water for injections; sodium hydroxide; hydrochloric acid; sodium chloride; citric acid monohydrate; disodium edetate - for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications.) for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.) for bronchospasm occurring during anaesthesia. as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use)

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - oxytocin, quantity: 5 iu; ergometrine maleate, quantity: 0.5 mg - injection, solution - excipient ingredients: sodium chloride; maleic acid; water for injections; acetic acid; sodium acetate trihydrate; chlorobutanol hemihydrate - active management of the third stage of labour. prevention and treatment of post-partum haemorrhage associated with uterine atony.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - oxytocin, quantity: 5 iu/ml - injection, solution - excipient ingredients: glacial acetic acid; chlorobutanol hemihydrate; water for injections; sodium acetate trihydrate; ethanol - induction of labour; inadequate uterine effort; management of third stage of labour; post-partum haemorrhage.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - oxytocin, quantity: 10 iu/ml - injection, solution - excipient ingredients: sodium acetate trihydrate; chlorobutanol hemihydrate; ethanol; glacial acetic acid; water for injections - induction of labour; inadequate uterine effort; management of third stage of labour; post-partum haemorrhage.